These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1995194)

  • 21. [MRI of the pituitary adenomas with reference to the hormonal activity].
    Masunaga S; Asato R; Kikuchi H; Matsumoto S; Nagata I; Hashimoto N; Takahashi J; Kohno K; Konishi J
    No To Shinkei; 1995 Dec; 47(12):1165-9. PubMed ID: 8534553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of pituitary tumours and hyperprolactinemia in female rats by estrogens. The effect of apomorphine, reserpine and L-dopa.
    Koch M; Oettel M; Lauterbach H; Freund H
    Arch Toxicol Suppl; 1980; 4():89-91. PubMed ID: 6933973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.
    Lloyd RV
    Am J Pathol; 1983 Nov; 113(2):198-206. PubMed ID: 6638150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Increased T1 signal of the residual normal anterior pituitary gland following medical treatment of pituitary prolactinoma].
    Bonneville F; Cattin F; Barrali E; Lucas X; Narboux Y; Bonneville J
    J Radiol; 2001 Apr; 82(4):501-5. PubMed ID: 11353909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic monoaminergic activity and pituitary function in male rats with estrogen-induced pituitary hyperplasia.
    Terry LC; Craig R; Hughes T; Schatzle J; Zorza M; Ortolano GA; Willoughby JO
    Neuroendocrinology; 1985 Oct; 41(4):269-75. PubMed ID: 3930985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study.
    Chanson P; Daujat F; Young J; Bellucci A; Kujas M; Doyon D; Schaison G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3009-15. PubMed ID: 11443160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland.
    Spady TJ; McComb RD; Shull JD
    Endocrine; 1999 Dec; 11(3):217-33. PubMed ID: 10786818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
    Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
    Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenicity and hormone studies with the tissue-selective estrogen receptor modulator bazadoxifene.
    Wright DJ; Earnhardt JN; Perry R; Bailey S; Komm B; Minck DR; Cukierski MA
    J Cell Physiol; 2013 Apr; 228(4):724-33. PubMed ID: 22949219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of anterior pituitary folliculo-stellate cells in the formation of estrogen-induced prolactin-secreting tumors.
    Schechter J; Ahmad N; Weiner R
    Neuroendocrinology; 1988 Nov; 48(5):569-76. PubMed ID: 2469030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estrogen and tamoxifen on the ultrastructural characteristics of female rat prolactin cells as evaluated by immunogold technique.
    Erensoy N; Cagatay P; Yilmazer S
    Acta Histochem; 2005; 107(3):199-205. PubMed ID: 15993477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual documentation of ovine pituitary gland development with magnetic resonance imaging following zeranol treatment.
    Carroll JA; Walker MA; Hartsfield SM; McArthur NH; Welsh TH
    Lab Anim; 2007 Jan; 41(1):120-7. PubMed ID: 17234058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype.
    Spady TJ; Pennington KL; McComb RD; Shull JD
    Endocrinology; 1999 Jun; 140(6):2828-35. PubMed ID: 10342874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin and aging: X-irradiated and estrogen-induced rat mammary tumorigenesis.
    Ito A; Naito M; Watanabe H; Yokoro K
    J Natl Cancer Inst; 1984 Jul; 73(1):123-6. PubMed ID: 6588219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary hormones and prolactin-releasing activity in rats with primary estrogen-induced pituitary tumors.
    Nakagawa K; Obara T; Tashiro K
    Endocrinology; 1980 Mar; 106(3):1033-9. PubMed ID: 7353534
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen-induced pituitary tumor development in the ACI rat not inhibited by dietary energy restriction.
    Spady TJ; Pennington KL; McComb RD; Birt DF; Shull JD
    Mol Carcinog; 1999 Dec; 26(4):239-53. PubMed ID: 10569801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
    Leger J; Velasquez A; Garel C; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1954-60. PubMed ID: 10372693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue.
    Maeda T; Lloyd RV
    Lab Invest; 1993 Apr; 68(4):472-80. PubMed ID: 8479155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction.
    Nishioka H; Shibuya M; Ohtsuka K; Ikeda Y; Haraoka J
    Neuroradiology; 2010 Nov; 52(11):997-1002. PubMed ID: 20238110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.